Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
18th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Categories
Categories
Adalta (1AD)
Amplia Therapeutics (ATX)
Anteris Technologies (AVR)
Antisense Therapeutics (ANP)
Aroa Biosurgery (ARX)
Bio-Gene Technology (BGT)
Blinklab (BB1)
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
EBR Systems (EBR)
Immuron (IMC)
Imricor Medical Systems (IMR)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Opthea (OPT)
Patrys (PAB)
Radiopharm Theranostics (RAD)
ResApp Health (RAP)
Respiri (RSH)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
October 11th, 2024
Amplia Reaches Positive Endpoint After 16 Patients Treated
Read More
Pages
1
